0000947871-13-000521.txt : 20130717 0000947871-13-000521.hdr.sgml : 20130717 20130717192058 ACCESSION NUMBER: 0000947871-13-000521 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130715 FILED AS OF DATE: 20130717 DATE AS OF CHANGE: 20130717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WebMD Health Corp. CENTRAL INDEX KEY: 0001326583 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 202783228 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 EIGHTH AVE. CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 212-624-3700 MAIL ADDRESS: STREET 1: 111 EIGHTH AVE. CITY: NEW YORK STATE: NY ZIP: 10011 FORMER COMPANY: FORMER CONFORMED NAME: WebMD Health Holdings, Inc. DATE OF NAME CHANGE: 20050510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH JOSEPH E CENTRAL INDEX KEY: 0001230617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35337 FILM NUMBER: 13973618 4 1 ss182033_4-smith.xml OWNERSHIP DOCUMENT X0306 4 2013-07-15 0 0001326583 WebMD Health Corp. WBMD 0001230617 SMITH JOSEPH E 111 EIGHTH AVENUE NEW YORK NY 10011 1 0 0 0 Common Stock 2013-07-15 4 M 0 8888 20.23 A 48217 D Common Stock 2013-07-15 4 M 0 8888 18.37 A 57105 D Common Stock 2013-07-15 4 M 0 8888 19.04 A 65993 D Common Stock 2013-07-15 4 S 0 26664 32.04 D 39329 D Stock Option (Right to Buy) 20.23 2013-07-15 4 M 0 8888 0 D 2009-10-23 2014-01-01 Common Stock 8888 0 D Stock Option (Right to Buy) 18.37 2013-07-15 4 M 0 8888 0 D 2009-10-23 2015-01-01 Common Stock 8888 0 D Stock Option (Right to Buy) 19.04 2013-07-15 4 M 0 8888 0 D 2016-01-01 Common Stock 8888 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.04 to $32.06 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. 25% of the shares underlying the option vested on the first anniversary of the grant date and 1/48 of the shares vested monthly thereafter over the next three-year period (fully vested on the 4th anniversary of the grant date). The date of grant for the option was ten years prior to the expiration date. /s/ Lewis H. Leicher, Attorney-in-Fact for Joseph E. Smith 2013-07-17